Down-modulation of poly(ADP-ribose) polymerase-1 (PARP-1) in human TUR leukemia cells restores transcriptional responsiveness for differentiation and cell cycle arrest

被引:17
作者
Harnacke, K
Kruhoffer, M
Orntoft, TF
Hass, R
机构
[1] Sch Med, Dept Biochem & Tumor Biol, D-30625 Hannover, Germany
[2] Aarhus Univ Hosp, Dept Clin Biochem, Mol Diagnost Lab, Aarhus N, Denmark
[3] AROS Appl Biotechnol AS, Aarhus N, Denmark
关键词
PARP; differentiation; cell cycle regulation; TUR leukemia cells; gene arrays;
D O I
10.1016/j.ejcb.2005.08.009
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aggressive tumor developing human TUR myeloid leukemia cells continued cell cycle progression in the presence of the differentiation-inducing phorbol ester 12-O-tetradecanoylphorbol- 13-acetate (TPA). Similar results were obtained after stable transfection of TUR cells with the pTracer control vector (pTracer TUR cells). In contrast, TUR transfectants containing a constitutively active poly(ADP-ribose) polymerase-1 (PARP-1) gene fragment in antisense orientation within the pTracer vector (asPARP TUR cells) demonstrated increasing cell attachment and differentiation after TPA treatment. Moreover, asPARP TUR cells ceased to divide upon TPA stimulation. Cell cycle analysis revealed a predominant G(0)/G(1) arrest and a partial G(2)/M arrest in TPA-treated asPARP TUR cells, whereas little if any population was detectable in S phase. Microarray gene expression analysis exhibited a significant down-regulation of cell cycle genes in phorbol ester-stimulated asPARP TUR and markedly elevated levels of differentiation-associated factors in contrast to TPA-incubated wild-type TUR cells. Whereas PARP- I can associate with the 20S proteasome in leukemia cells, a significant reduction of this proteolytic activity was observed in asPARP TUR cells. Conversely, protein levels of manganese superoxide dismutase and the matrix metalloproteinases MMP-1 and MMP-9 were progressively increased in TPA-treated asPARP TUR cells, respectively. These findings underscore an important function of PARP- I in human leukemia cells to connect cell cycle progression and control of differentiation. (c) 2005 Elsevier GmbH. All rights reserved.
引用
收藏
页码:885 / 896
页数:12
相关论文
共 54 条
  • [1] Regulatory mechanisms of poly(ADP-ribose)polymerase
    Alvarez-Gonzalez, R
    Watkins, TA
    Gill, PK
    Reed, JL
    Mendoza-Alvarez, H
    [J]. MOLECULAR AND CELLULAR BIOCHEMISTRY, 1999, 193 (1-2) : 19 - 22
  • [2] PARP-2, a novel mammalian DNA damage-dependent poly(ADP-ribose) polymerase
    Amé, JC
    Rolli, V
    Schreiber, V
    Niedergang, C
    Apiou, F
    Decker, P
    Muller, S
    Hoger, T
    Murcia, JMD
    de Murcia, G
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) : 17860 - 17868
  • [3] AME JC, 2000, DNA DAMAGE STRESS SI, P1
  • [4] PARP-1, a determinant of cell survival in response to DNA damage
    Bouchard, WJ
    Rouleau, M
    Poirier, GG
    [J]. EXPERIMENTAL HEMATOLOGY, 2003, 31 (06) : 446 - 454
  • [5] IONIZING-RADIATION INDUCES EXPRESSION AND BINDING-ACTIVITY OF THE NUCLEAR FACTOR-KAPPA-B
    BRACH, MA
    HASS, R
    SHERMAN, ML
    GUNJI, H
    WEICHSELBAUM, R
    KUFE, D
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (02) : 691 - 695
  • [6] Butler AJ, 1999, MOL CELL BIOL, V19, P296
  • [7] Transcription regulation of TNF-α-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells
    Carrillo, A
    Monreal, Y
    Ramírez, P
    Marin, L
    Parrilla, P
    Oliver, FJ
    Yélamos, J
    [J]. NUCLEIC ACIDS RESEARCH, 2004, 32 (02) : 757 - 766
  • [8] The sequence-specific DNA binding of NF-κB is reversibly regulated by the automodification reaction of poly (ADP-ribose) polymerase 1
    Chang, WJ
    Alvarez-Gonzalez, R
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (50) : 47664 - 47670
  • [9] Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesist' revisited
    Chiarugi, A
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2002, 23 (03) : 122 - 129
  • [10] Regulation of the nuclear proteasome activity in myelomonocytic human leukemia cells after adriamycin treatment
    Ciftci, Ö
    Ulrich, O
    Schmidt, CA
    Diestel, A
    Hass, R
    [J]. BLOOD, 2001, 97 (09) : 2830 - 2838